首页> 外国专利> NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS

机译:新型化合物在治疗中枢神经系统疾病和疾病中的优势

摘要

A series of novel amides showing broad pharmaceutical activity. Compounds described herein are effective as anticonvulsants, chemical countermeasures, and analgesics. Such compounds also show, neuroprotective/neuroreparative effects and activity against spinal muscular atrophy. Such pharmaceutically active compounds show utility in the treatment of central nervous system ("CNS") diseases and disorders, such as anxiety, depression, insomnia, migraine headaches, schizophrenia, neurodegenerative diseases (e.g., Parkinson's disease, Alzheimer's, ALS, and Huntington's disease) spasticity, and bipolar disorder. Furthermore, such compounds may additionally find utility as analgesics (e.g., for the treatment of chronic or neuropathic pain) and as neuroprotective agents useful in the treatment of stroke(s), and/or traumatic brain and/or spinal cord injuries.
机译:一系列具有广泛药物活性的新型酰胺。本文所述的化合物可有效用作抗惊厥药,化学对策和止痛药。这类化合物还显示出神经保护/神经修复作用和抗脊髓性肌萎缩的活性。此类药物活性化合物在治疗中枢神经系统(“ CNS”)疾病和病症(例如焦虑症,抑郁症,失眠症,偏头痛,精神分裂症,神经退行性疾病(例如帕金森氏病,阿尔茨海默氏病,ALS和亨廷顿氏病)中显示出效用)痉挛和躁郁症。此外,这些化合物还可以用作止痛药(例如,用于治疗慢性或神经性疼痛)和用作在治疗中风和/或外伤性脑和/或脊髓损伤中有用的神经保护剂。

著录项

  • 公开/公告号WO2017066103A1

    专利类型

  • 公开/公告日2017-04-20

    原文格式PDF

  • 申请/专利权人 AURIMMED PHARMA INC.;

    申请/专利号WO2016US56152

  • 发明设计人 BALANDRIN MANUEL F.;PESYAN AMIR;

    申请日2016-10-07

  • 分类号A61K31/343;C07D295/155;C07D307/81;

  • 国家 WO

  • 入库时间 2022-08-21 13:31:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号